T2 Biosystems Receives MedTech IGNITE Award

(Nanowerk News) T2 Biosystems, Inc., a company developing the first point-of-care medical diagnostic products that enable rapid molecular and immunodiagnostic testing on a single instrument, today announced it has won the MedTech IGNITE Innovative Technology Competition, an award that honors a ground-breaking medical device innovation with outstanding market potential.
T2 Biosystems will receive the award, sponsored by Manta Product Development, Inc., at the MassMEDIC Investors Conference today at the U Mass Boston Campus Center.
"We are honored to receive this award, which acknowledges the breakthrough potential of T2 Biosystems' revolutionary technology that eliminates extensive sample preparation for medical diagnostics," said John McDonough, CEO of T2 Biosystems. "This award recognizes the vision of T2's founders, as well as the innovation and scientific breakthroughs created by our world-class scientists and engineers."
T2 Biosystems is developing the next generation of medical diagnostic products through its proprietary technology, which combines nanotechnology and the miniaturization of proven magnetic resonance (MR) technology. T2 Biosystems' diagnostics are poised to offer improved speed, accuracy and efficiency as well as portability to a broader range of settings including doctor's offices, homes and hospitals.
T2 Biosystems' technology has been validated in multiple published journal articles and has accurately analyzed viruses, bacteria, proteins, hormones, DNA, small molecules and other diagnostic targets. The Company is developing a pipeline of diagnostic products based on its technology, including devices for hospitals, diagnostic laboratories and medical offices, as well as individual patients.
About T2 Biosystems
T2 Biosystems is a private biotechnology company developing next-generation medical diagnostic products using its proprietary technology, combining nanotechnology and miniaturized magnetic resonance (MR) technology to provide rapid, accurate and portable diagnostics. T2 Biosystems was founded in 2006 by renowned researchers from the Massachusetts Institute of Technology, Harvard University, Harvard Medical School and Massachusetts General Hospital, and has assembled a world-class team, board of directors and scientific advisory board that collectively have a proven track record of translating technologic innovations into breakthrough products, building significant corporate value. T2 Biosystems is located in Cambridge, Massachusetts. For more information, please visit the company's website at www.t2biosystems.com.
Source: T2 Biosystems (press release)
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: